The HSE says no patient received a potentially contaminated Chemotherapy product after it was recalled.
The clarification follows reports that suggested the drug had been used this week, after the health service was notified of an issue with it.
The HSE says it became aware of the situation last Monday and that immediate and co-ordinated action was undertaken by all oncology teams throughout the country to contact the 200 patients concerned.
